Literature DB >> 54397

Effects of IgM and IgG antibody in patients with bacteremia due to gram-negative bacilli.

S H Zinner, W R McCabe.   

Abstract

Earlier studies, which indicated that high titers of O-specific antibody to the patient's infecting organism in acute-phase serum specimens were not associated with a decrease in the frequency of subsequent shock and death in bacteremia due to gram-negative bacilli, were reexamined for evaluation of the protective activity of specific IgG and IgM antibody. Titers of hemagglutination antibody and levels of IgM, determined by indirect immunofluorescent staining of the patient's infecting organism, as well as hemagglutination titers after reduction of serum with 2-mercaptoethanol and IgG levels, correlated closely (P less than 0.001). High titers of IgG antibody to the patient's infecting organism in acute-phase specimens were associated with a significant reduction in the frequency of shock and death in bacteremia. In contrast, high titers of IgG antibody were not associated with a diminution in the frequency of shock and death. The previously demonstrated protective activity of antibody to an antigen, Re lipopolysaccharide, shared by most gram-negative bacilli was reconfirmed and shown to be independent of the protective activity of O-specific IgG antibody.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 54397     DOI: 10.1093/infdis/133.1.37

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

Review 1.  Immunotherapeutic advances in the treatment of gram-negative bacterial sepsis.

Authors:  D L Dunn
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

2.  A direct enzyme-linked immunosorbent assay (ELISA) for antibodies to enterobacterial Re core glycolipid and lipid A. Results in healthy subjects and in patients infected by gram-negative bacteria.

Authors:  M Nys; P Damas; F Damas; L Joassin; J Demonty
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

Review 3.  Bactericidal and bacteriolytic activity of serum against gram-negative bacteria.

Authors:  P W Taylor
Journal:  Microbiol Rev       Date:  1983-03

4.  In vivo and in vitro humoral immunity in surgical patients.

Authors:  C W Nohr; N V Christou; H Rode; J Gordon; J L Meakins
Journal:  Ann Surg       Date:  1984-09       Impact factor: 12.969

Review 5.  Immunological aspects to severe bacterial sepsis.

Authors:  N Clumeck; C George
Journal:  Intensive Care Med       Date:  1981-04       Impact factor: 17.440

6.  Top Down Tandem Mass Spectrometric Analysis of a Chemically Modified Rough-Type Lipopolysaccharide Vaccine Candidate.

Authors:  Benjamin L Oyler; Mohd M Khan; Donald F Smith; Erin M Harberts; David P A Kilgour; Robert K Ernst; Alan S Cross; David R Goodlett
Journal:  J Am Soc Mass Spectrom       Date:  2018-02-20       Impact factor: 3.109

7.  Functional properties of isotype-switched immunoglobulin M (IgM) and IgG monoclonal antibodies to Pseudomonas aeruginosa lipopolysaccharide.

Authors:  M Pollack; N L Koles; M J Preston; B J Brown; G B Pier
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

8.  Immunization with R mutants of Salmonella minnesota. II. Comparison of the protective effect of immunization with lipid A and the Re mutant.

Authors:  S C Bruins; R Stumacher; M A Johns; W R McCabe
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

9.  Longitudinal study of antibody response to lipopolysaccharides during chronic Pseudomonas aeruginosa lung infection in cystic fibrosis.

Authors:  A Fomsgaard; N Høiby; G H Shand; R S Conrad; C Galanos
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

10.  Circulating immune complexes in patients with gram negative septic shock.

Authors:  C George; J Carlet; A Sobel; L Intrator; M Robin; C Sabatier; D Prevot; M Rapin
Journal:  Intensive Care Med       Date:  1980       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.